Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress
- Increased focus on balloon technology at industry events demonstrates changing obesity treatment landscape.
- Allurion committed to making gastric balloon technology available to as many people as possible.
- Gastric balloons provide an alternative to surgery that is less invasive and highly effective.
- None.
Congress convenes the world’s leading bariatric healthcare professionals to discuss innovative therapies
The IBC event, entitled ‘Managing Obesity and Diabetes: From the Laboratory to the Clinic to the Operating Room to the World’, will bring together many of the world’s most distinguished weight-loss experts.
Brazilian bariatric surgeon Professor Eduardo Grecco’s presentation, ‘The Perfect Intra-gastric Balloon: Combining Safety with Satiety’, will discuss the role the Allurion Balloon—and all the elements of the Allurion Program—can play in safely and effectively delivering weight loss.
Professor Grecco, a gastric surgeon and endoscopist at Instituto Endovitta in São Paulo, is among the specialists worldwide who are now routinely treating patients with the Allurion Program, a full-stack weight loss program featuring the world’s first and only swallowable, procedure-less intragastric balloon, AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth delivered by the Allurion Virtual Care Suite. His clinic has been using the Allurion Balloon to help patients lose weight since it was approved by the Brazilian Health Regulatory Agency ANVISA in 2022.
To build further on this theme, the Congress Experts’ Forum Discussion Session is entitled ‘Battle of the Balloons: Endoscopic Vs Swallowable’. It will be chaired by Professor Grecco and Professor Salman Al Sabah, Director of Surgical Research and a Consultant Surgeon at both Al-Amiri Hospital and the Royale Hayat Hospital in
Allurion’s Senior Director of Global Nutrition, Zoe Griffiths, says the increased focus on balloon technology at industry events such as IBC demonstrates the changing obesity treatment landscape.
"Gastric balloon research has evolved enormously in the last 10 years and Allurion is proud of its commitment to making this technology available to as many people as possible, and combining it with cutting edge techniques in behavior change and artificial intelligence to optimize outcomes,” she said.
“Our research shows that people who are living with overweight and obesity want options, and we believe balloons provide an alternative to surgery that is less invasive and highly effective. We also know that there is no one-size-fits-all solution to weight loss. Gastric balloons can be used on their own or in combination with a range of other treatments, including surgery and weight-loss medications.”
For more information about IBC, please visit: https://www.ibcclub.org
Presentation Information
Title: The Perfect Intra-gastric Balloon: Combining Safety with Satiety
Presenter: Dr. Eduardo Grecco, Bariatric Endoscopist at EndoVitta Institute,
Presentation Date: Monday, September 18th 2023, at 12:35 PM
Title: Experts’ Forum Discussion Session: Battle of the Balloons: Endoscopic Vs Swallowable
Chairs: Drs. Eduardo Grecco (
Panel: Drs. Joao Henrique Felicio de
Presentation Date: Monday, September 18th 2023, at 18:25 PM
About Allurion
Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in
For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.
Forward-Looking Statements
This press release may contain certain forward-looking statements within the meaning of the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230918145389/en/
Media Contact
Cedric Damour
PR Manager
+33 7 84 21 02 20
cdamour@allurion.com
Source: Allurion Technologies, Inc.